top of page

FDA Approves OTC Nasal Spray

The FDA's approval of a third over-the-counter opioid overdose nasal spray marks another important step in expanding access to life-saving medications.

By stocking OTC naloxone products and educating patients, caregivers, schools, businesses, and community organizations on their use, independent pharmacies can further their role as a community healthcare provider by:


✔ Increasing community access to overdose reversal medications

✔ Strengthening public health outreach efforts

✔ Positioning themselves as trusted healthcare resources beyond prescription dispensing

✔ Playing a critical role in addressing the ongoing opioid crisis

As naloxone becomes increasingly accessible, independent pharmacies remain uniquely positioned to bridge the gap between availability and awareness—ensuring these life-saving products reach the people who need them most.


 
 
 

Comments


bottom of page